EUVIMEDEUVIMED entdecken
Crossref

Bone-Targeting Nucleic Acid Delivery Polymer Vector for Effective Therapy of Bone Metastasis

Zejuan Li iD, Xiao Xiao iD, Xu Pu iD, Xingsen Yang iD, Junqiu Shi iD, Shisheng He, Jianzhong Du iD, Yunqing Zhu iD

ACS Nano · 06.05.2025 · 19 (17) · 17014-17027

DOI: 10.1021/acsnano.5c04743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 24.04.2025. Verfasst von Zejuan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China. Hauptthemen laut MEDLINE: Bone Neoplasms, MicroRNAs, Polymers, Nucleic Acids. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Shanghai Municipal Education Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone diseases, such as bone metastases, pose significant therapeutic challenges due to the distinct physiological environment of skeletal tissues, which complicates the targeted delivery of nucleic acid therapeutics. Existing delivery systems, including lipid nanoparticles (LNP) and polyethylenimine (PEI), struggle to achieve precise bone targeting effectively. To address this issue, we developed a polymer-based bone-targeting bioreducible nucleic acid delivery vector, poly[alendronic acid-co-(N,N'-bis(acryloyl)cystamine-co-4-amino-1-butanol)] (ALN-Pabol), which incorporates alendronic acid (ALN) for precise bone targeting. The ALN-Pabol exhibited a hydroxyapatite binding rate of 91.1%, significantly outperforming nontargeted Pabol/miRNA (73.5%) and commercial systems such as PEI/miRNA (58.3%) and Lipofectamine 2000/miRNA (64.7%). In vivo fluorescence imaging demonstrated its superior skeletal accumulation compared to nontargeted controls. In a murine breast cancer bone metastasis model, ALN-Pabol/miRNA polyplex reduced bone tumor weight by 79.1% relative to PBS controls and 36.8% compared to LNP/miRNA. Mechanistically, the polyplex dissociates in the high-glutathione tumor microenvironment, releasing therapeutic miRNA to suppress cancer cell proliferation and promote apoptosis. Simultaneously, ALN inhibits osteoclast activity, significantly mitigating osteolytic damage. Micro-CT analysis revealed near-complete restoration of bone volume and trabecular architecture to healthy levels. This work establishes ALN-Pabol as a highly promising delivery vector for bone-targeted gene therapy, bridging critical gaps in skeletal disease treatment and expanding potential applications in bone regeneration and cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsMicroRNAsPolymersNucleic AcidsAnimalsMiceHumansFemaleNanoparticlesCell Line, TumorAlendronate

Stichwörter der Autor:innen

alendronic acidbone metastasesbone targetingdelivery vectornucleic acidpolyamidoamines

Substanzen

MicroRNAsPolymersNucleic AcidsAlendronate

Autor:innen und Institutionen

  • Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China.
  • Department of Gynaecology and Obstetrics, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institu…
  • Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Yanchang Road 301, Shanghai 200072, China.
  • Key Laboratory of Advanced Civil Engineering Materials of Ministry of Education, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China.
  • School of Materials Science and Engineering, East China University of Science and Technology, Shanghai 200237, China.

ORCID-Profile: Zejuan Li, Xiao Xiao, Xu Pu, Xingsen Yang, Junqiu Shi, Jianzhong Du, Yunqing Zhu

Förderung

  • National Key Research and Development Program of China
  • Shanghai Municipal Education Commission
  • National Natural Science Foundation of China
  • Tongji University
  • Tongcheng Youth Research and Development Fund

Zitieren

APA

Li, Z., Xiao, X., Pu, X., Yang, X., Shi, J., He, S., Du, J., & Zhu, Y. (2025). Bone-Targeting Nucleic Acid Delivery Polymer Vector for Effective Therapy of Bone Metastasis. ACS Nano, 19(17), 17014-17027. https://doi.org/10.1021/acsnano.5c04743

Vancouver

Li Z, Xiao X, Pu X, Yang X, Shi J, He S, et al. Bone-Targeting Nucleic Acid Delivery Polymer Vector for Effective Therapy of Bone Metastasis. ACS Nano. 2025;19(17):17014-17027. doi:10.1021/acsnano.5c04743

BibTeX
@article{Li2025,
  author = {Li, Zejuan and Xiao, Xiao and Pu, Xu and Yang, Xingsen and Shi, Junqiu and He, Shisheng and Du, Jianzhong and Zhu, Yunqing},
  title = {Bone-Targeting Nucleic Acid Delivery Polymer Vector for Effective Therapy of Bone Metastasis},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {17},
  pages = {17014--17027},
  doi = {10.1021/acsnano.5c04743}
}
Kostenlos starten →